sr 95531 has been researched along with norfloxacin in 1 studies
| Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (norfloxacin) | Trials (norfloxacin) | Recent Studies (post-2010) (norfloxacin) |
|---|---|---|---|---|---|
| 610 | 0 | 209 | 3,077 | 280 | 912 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akahane, K; Fukuda, H; Ito, Y; Kimura, Y; Miyasaka, T | 1 |
1 other study(ies) available for sr 95531 and norfloxacin
| Article | Year |
|---|---|
Inhibition of GABAA receptor chloride channel by quinolones and norfloxacin-biphenylacetic acid hybrid compounds.
Topics: Animals; Anti-Infective Agents; Chloride Channels; Chlorine; Enoxacin; GABA Agonists; GABA Antagonists; GABA-A Receptor Antagonists; Male; Muscimol; Norfloxacin; Phenylacetates; Pyridazines; Quinolones; Rats; Rats, Wistar; Synaptosomes | 1996 |